Skip to main content

Nonsteroidal Anti-Inflammatory Drugs

  • Chapter
  • First Online:
Pain

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class of prescription and over-the-counter compounds used both as for mild to moderate pain, fever, swelling and inflammation They work by inhibiting cyclooxygenase (COX) enzymes in the arachidonic acid pathway to block the production of prostaglandins. They are available for ophthalmic, otic, topical/external, parenteral, oral, and rectal routes of administration. Severe drug-class adverse effects include stroke, myocardial infarction, renal insufficiency, bleeding, and gastrointestinal bleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grosser T, Smyth E, FitzGerald GA. Anti-inflammatory, antipyretic, and analgesic agents; pharmacotherapy of gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The pharmacological basis of therapeutics, 12e. New York: McGraw-Hill. http://accessmedicine.mhmedical.com.ezproxy.library.wisc.edu/content.aspx?bookid=1613&sectionid=102161048. Accessed 27 Oct 2017.

  2. Wolters Kluwer clinical drug information, Inc. Lexi-Drugs [online database]. Wolters Kluwer Clinical Drug Information, Inc.; October 28, 2017.

    Google Scholar 

  3. Fosbøl EL, Folke F, et al. Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circ Cardiovasc Qual Outcomes. 2010;3(4):395–405.

    Article  Google Scholar 

  4. García Rodríguez LA, Tacconelli S, Patrignani P. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. J Am Coll Cardiol. 2008;52(20):1628–36.

    Article  Google Scholar 

  5. Catella-Lawson F, Reilly MP, et al. Cyclooxygenase inhibitors and the antiplatelet effect of aspirin. N Engl J Med. 2001;345:1809–17.

    Article  CAS  Google Scholar 

  6. Wall, CG. Eastman, DK. NSAID gastropathy in peptic ulcer disease. In: Murphy JE, Lee MW, editors. Pharmacotherapy self-assessment program, 2016 Book 2. GI/fluids and nutrition. Lenexa: American College of Clinical Pharmacy; 2016. p. 49–59.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christi Ann Albert PharmD, BCPS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Albert, C.A. (2019). Nonsteroidal Anti-Inflammatory Drugs. In: Abd-Elsayed, A. (eds) Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-99124-5_54

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-99124-5_54

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-99123-8

  • Online ISBN: 978-3-319-99124-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics